Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nr23
    Member
    • Oct 2012
    • 42

    #1

    Cuffdiff output shows log2(fold change) as infinite

    Hi, I've compared two conditions in cuffdiff (2 reps each). On examining the output, I see in the gene_exp.diff file that some of the XLOC features show 'NOTEST' under the status column, and '-inf' under the log2(fold change) column.

    I've never seen this before, and it's worrying me as it produces weird plots in cummeRbund...

    Any help would be great!

    Best,

    N
  • mattia
    Member
    • Aug 2011
    • 30

    #2
    log(zero)=-inf

    I think you have 0 as a mean value (between replicates) in first condition (eg Treatment) and a number as mean value (between replicates) in the second condition(eg Control), so:
    log2(FoldChange)=log2(meanTreatment/meanControl)=log2(0/number)=log2(0)=-inf

    For "NOTEST", see the manual here in "Cuffdiff output" section.

    Comment

    • nr23
      Member
      • Oct 2012
      • 42

      #3
      So this isn't actually a bad thing, so to speak? If that's the case, I would have expected to see this sort of result quite frequently, where one condition has 0 reads mapping to a given gene and the other does have reads mapping.

      I'm still worried/confused though, as when I run my results through cummerbund, and look for sigGenes, I find no genes with p<0.01, whereas looking through the gene_exp.diff I find many...

      Do you know why this might be?

      N

      Comment

      • sdriscoll
        I like code
        • Sep 2009
        • 436

        #4
        When you're looking at the gene_exp.diff are you checking the q-value column or the p-value column? I think cummerbund uses the q-value column, which is correct.

        Also +/- inf fold changes are totally normal. I think cuffdiff used to report either a very large number or a very small number in the past instead of 'inf'. So if you're used to using this program in the past then maybe you were used to those results?
        /* Shawn Driscoll, Gene Expression Laboratory, Pfaff
        Salk Institute for Biological Studies, La Jolla, CA, USA */

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 12:22 PM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-11-2026, 10:35 AM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Working...